Maria Marketou - Concepedia

Author

Maria Marketou

Also Known As

Emmanouil Foukarakis, K. Toba, M E Marketou, M M Marketou, M MARKETOU, M Marketou, M. Boehm, M. E. Marketou, M. Marketou, M. Popovici

233

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Heraklion University of Crete Chania General Hospital ”St. George”Boston University National and Kapodistrian University of Athens

About

Maria Marketou is an author at University Hospital of Heraklion specializing in medicine, hypertension, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	664
2	Public Health	2	2	141
3	Engineering	1	1	17
4	Social Sciences	1	1	23
5	Biomedical Engineering	1	1	27

Maria Marketou

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension Joanna Kontaraki, Maria Marketou, Evangelos Zacharis, Journal of Human Hypertension HypertensionMolecular PhysiologyCardiovascular DiseaseNovel TargetsDifferential Expression	2013	111
MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage Joanna Kontaraki, Maria Marketou, Evangelos Zacharis, Journal of the American Society of Hypertension HypertensionTarget-organ DamageCardiovascular DiseaseMicrorna-126 Expression LevelsAntihypertensive Therapy	2014	107
Low-Dose Amiodarone Versus Sotalol for Suppression of Recurrent Symptomatic Atrial Fibrillation George Kochiadakis, Nikos E. Igoumenidis, Maria Marketou, The American Journal of Cardiology Cardiovascular DiseaseMedicineCardiovascular PharmacologyPharmacotherapyAtrial Fibrillation	1998	83
A Comparative Study of the Efficacy and Safety of Procainamide Versus Propafenone Versus Amiodarone for the Conversion of Recent-Onset Atrial Fibrillation George Kochiadakis, Nikos E. Igoumenidis, Michail E. Hamilos, The American Journal of Cardiology ThrombosisRecent-onset Atrial FibrillationCardiac AnaesthesiaCardiovascular DiseasePharmacology	2007	58
Amiodarone, Sotalol, or Propafenone in Atrial Fibrillation: Which Is Preferred to Maintain Normal Sinus Rhythm? George E. Kochiadakis, Maria Marketou, Nikos E. Igoumenidis, Pacing and Clinical Electrophysiology	2000	55
Intravenous Propafenone Versus Intravenous Amiodarone in the Management of Atrial Fibrillation of Recent Onset: A Placebo‐Controlled Study George Kochiadakis, Nikos E. Igoumenidis, Εmmanuel Simantirakis, Pacing and Clinical Electrophysiology	1998	51
Cardioprotective Effects of a Selective B2 Receptor Agonist of Bradykinin Post-Acute Myocardial Infarct Maria Marketou, Ekaterina Kintsurashvili, Kyriakos N. Papanicolaou, American Journal of Hypertension	2010	46
Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension Joanna Kontaraki, Maria Marketou, Fragiskos Parthenakis, Journal of the American Society of Hypertension HypertensionHeart FailureCardiomyopathyCardiovascular DiseasePhysiology	2015	45
Essential hypertension in the pathogenesis of age-related macular degeneration Vasiliki Katsi, Maria Marketou, Dimitrios A. Vrachatis, Journal of Hypertension	2015	41
Detection of abnormal left ventricular geometry in patients without cardiovascular disease through machine learning: An ECG‐based approach Eleni Angelaki, Maria Marketou, Georgios D. Barmparis, Journal of Clinical Hypertension	2021	38

Page 1